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Abstract
Background: Genetic reassortment plays a critical role in the generation of pandemic strains of influenza virus. The influenza
virus RNA polymerase, composed of PB1, PB2 and PA subunits, has been suggested to influence the efficiency of genetic
reassortment. However, the role of the RNA polymerase in the genetic reassortment is not well understood.
Methodology/Principal Findings: Here, we reconstituted reassortant ribonucleoprotein (RNP) complexes, and demon-
strated that the PB2 subunit of A/HongKong/156/1997 (H5N1) [HK PB2] dramatically reduced the synthesis of mRNA, cRNA
and vRNA when introduced into the polymerase of other influenza strains of H1N1 or H3N2. The HK PB2 had no significant
effect on the assembly of the polymerase trimeric complex, or on promoter binding activity or replication initiation activity
in vitro. However, the HK PB2 was found to remarkably impair the accumulation of RNP. This impaired accumulation and
activity of RNP was fully restored when four amino acids at position 108, 508, 524 and 627 of the HK PB2 were mutated.
Conclusions/Significance: Overall, we suggest that the PB2 subunit of influenza polymerase might play an important role
for the replication of reassortant ribonucleoprotein complexes.
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Introduction
Influenza A virus is a member of the family Orthomyxoviridae, and
classified into subtypes by antigenic differences of the two surface
glycoproteins, the hemagglutinin (HA) and the neuraminidase
(NA) [1]. All 16 HA and 9 NA subtypes are maintained in aquatic
birds and can be transmitted to various animals, including
humans, pigs, horses and birds. However, avian influenza strains
usually do not replicate efficiently in humans, and only three
subtypes of H1N1, H2N2 and H3N2 have established sustained
infection in human populations since the 1918 Spanish influenza,
suggesting a significant restriction of transmission and adaptation
of avian strains to humans.
The segmented genome structure of influenza virus facilitates
genetic reassortment with other influenza strains which is co-
infected in the same cells and has played a pivotal role in the
emergence of pandemics. The pandemic strains of the past century
have incorporated genes expressing the superficial HA and NA
glycoproteins giving rise to new subtypes with novel surface
antigens. Mutations of avian HA for acquiring human receptor a2,
6 sialic acid binding specificity is a prerequisite for human
adaptation. In addition to acquiring novel genes for superficial
glycoproteins, at least one internal gene of the RNA polymerase
from avian strains has been concurrently incorporated into human
strains. The1957 and 1968 influenza pandemics coincided with
the introduction of an avian PB1 gene [2]. Similarly, the 2009
pandemic was caused by a reassortant that acquired PB2 and PA
genes from an avian strain [3,4,5]. However, the contribution of
polymerase genes to pandemic emergence has not been elucidated
in detail.
The influenza virus RNA polymerase is a heterotrimeric
complex composed of three subunits, PB1, PB2 and PA, which
assembles with nucleoprotein (NP) and viral RNA, forming
ribonucleoprotein complex (RNP) [6,7]. The PB1 subunit contains
the S-D-D motif characteristic of polymerases and is directly
involved in RNA synthesis [8,9]. The PB2 subunit binds to the cap
structure at the 59 end of host mRNA to generate short capped
RNA fragments that are used as primers for viral transcription
[6,10]. The PA subunit plays a role in transcription and replication
through its endonuclease activity [11,12,13], promoter binding
[13,14,15,16], cap binding [13] and possible proteolytic activity
[17,18]. In addition to the central role of the RNA polymerase in
RNA synthesis, recent studies have suggested its potential role in
genetic reassortment [19,20,21,22]. Artificial hybrid RNA poly-
merases between human and avian influenza strains often exhibit
a functional loss in RNA replication. Reconstitution experiments
of influenza RNP in vivo has demonstrated that an introduction of
avian PB2 into a background of human strains has often led to a
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been suggested that a specific combination of avian PB2 with
human PA or human PB1 leads to a significant decrease in
polymerase activity [24,25]. However, the underlying mechanism
that restricts genetic reassortment is still unclear.
In this study, we attempted to characterize and dissect the role
of the polymerase genes in giving rise to a functional genetic
reassortant. We generated RNP containing hybrid polymerase
between human-isolated avian H5N1 and human H1N1 or
H3N2. Our results revealed that the PB2 subunit of H5N1 has a
strong inhibitory effect on the RNP activity when introduced into
the polymerase of other influenza strains. Importantly, H5N1 PB2
could form functional 3P complex properly, but significantly
reduced the accumulation of RNP, specifically through the
properties of four amino acids in PB2 at position 108, 508, 524
and 627.
Materials and Methods
Strains
cDNA clones isolated from the following influenza strains were
used: A/HongKong/156/1997 (H5N1) (abbreviated as HK or H),
A/Vietnam/1194/2004 (H5N1) (abbreviated as VN or V), A/
WSN/1933 (H1N1) (abbreviated as WSN or W), a newly
pandemic A/Kurume/K0910/2009 (H1N1) (abbreviated as SW
or S), A/NT/60/1968 (H3N2) (abbreviated as NT or N) [26].
Plasmids
PB1, PB2, PA and NP-expressing plasmids of influenza viruses
HK, VN, WSN, SW and NT have previously been described
[14,26,27]. The plasmid expressing vRNA of NA gene (vNA) from
WSN has also been described previously [28]. Mutants of the PB2
plasmids were prepared by site-directed mutagenesis and were
fully sequenced.
RNA isolation and primer extension assay in 293T cell
293T human embryonic kidney cells [12] were transfected with
0.2 mg each of PA, PB1, PB2, NP and vNA expression vector of
each strain (WSN, NT, HK, VN or SW) by using Lipofectamine
2000 (Invitrogen). Cells were harvested 30 h posttransfection, and
total RNA was isolated with TRIzol reagent (Invitrogen). RNA
was then analyzed in a primer extension assay using three primers-
one for vRNA, one for mRNA and cRNA, one for 5S rRNA as an
internal control [12,13]. Transcripts were visualized by 7%
polyacrylamide gel containing 7 M urea in TBE buffer and were
detected by autoradiography. Assays were carried out at least three
times with independently transfected cells.
Preparation of TAP-tagged polymerase and RNP and in
vitro assays
For a preparation of the polymerase, 293T cells were
transfected with expression vectors containing PB1, PB2 and
TAP-tagged PA subunit of each strain. For a preparation of the
RNP, NP and vNA expression vectors were also transfected
simultaneously. Cells were harvested 2 days posttransfection and
the polymerase or RNP was purified by the tandem affinity
purification (TAP) method described previously [27]. Partially
purified polymerase or RNP was analyzed by 7.5% SDS-PAGE
with silver staining (Invitrogen) and confirmed by western blotting
with specific antibody against PB1, PB2 and PA [17,29]. For in
vitro assays, the amount of the polymerase was quantitatively
adjusted. TAP purification procedure by PA TAP leads to co-
purify trimeric complex with PB1-PA TAP heterodimer and PA
TAP monomer, and the purified material reveals higher level of
PA than other subunits. Adjustments were made by the
quantitative measurements of the level of PB2 on silver-stained
SDS-PAGE gel, because PB2 indicates the level of trimeric
complex. The dinucleotide initiation of replication assay and UV
cross-linking to model vRNA and cRNA promoters were
performed as reported previously [16], and quantitated by
autoradiography and Quantity One software version 4.6.7 (Bio-
Rad).
Results
Effect of individual polymerase subunits of H5N1 on the
RNP activity when reconstituted with other polymerase
subunits of H1N1 or H3N2
In order to investigate the role of the RNA polymerase on the
restriction of genetic reassortment, we reconstituted reassortant
RNP by introducing the polymerase subunit of H5N1 into the
polymerase of H1N1 or H3N2. We used two human-isolated
H5N1 strains of A/HongKong/156/1997 [HK] and a closely
related A/Vietnam/1194/04 [VN], two human H1N1 strains of
A/WSN/33 [WSN] and the new pandemic influenza A/
Kurume/K0910/09 [SW], and H3N2 strain of A/NT/60/68
[NT], because these strains were extensively analyzed previously
[14,26]. The RNP was reconstituted in human 293T cells from
hybrid polymerase on the background of WSN. The steady-state
levels of NA reporter mRNA, vRNA and cRNA were measured by
primer extension.
In the case of the HK strain of H5N1 (Figure 1, left 3 panels),
the levels of mRNA, cRNA and vRNA were not significantly
affected when HK PB1 alone, HK PA alone, HK PB1 - HK PB2
or HK PB1 - HK PA was introduced into WSN polymerase
(Figure 1, lane 2, 4, 5 and 7). However, the RNP activity was
severely reduced to essentially inactive levels, with only back-
ground levels of input vRNA, when either HK PB2 alone or HK
PB2 - HK PA was introduced into WSN polymerase (Figure 1,
lane 3 and 6). A similar significant reduction of RNP activities was
also observed when either HK PB2 alone or HK PB2 - HK PB1
was introduced into SW (Figure 1, lanes 19 and 21) or NT
polymerases (Figure 1, lanes 35 and 37). These results apparently
showed that HK PB2 was responsible for the severe reduction of
RNP activity, because HK PB2 alone could decrease the activity.
This reduction of RNP activity was restored by HK PB1 in WSN
polymerase (Figure 1, lane 5), or HK PA in SW or NT polymerase
(Figure 1, lanes 22 and 38). On the other hand, in the case of the
VN strain of H5N1 (Figure 1, right 3 panels), such remarkable
reduction of RNP activity by the PB2 subunit was only observed
when introduced into NT polymerase (Figure 1, lanes 43 and 45).
VN PB2 did not show the inhibitory effect on either WSN or SW
polymerases (Figure 1, lane 11, 14, 27 and 29). On the contrary,
VN PB2 alone or VN PB2 - VN PB1 significantly increased the
activity of SW polymerase (Figure 1, lanes, 27 and 29). These
results indicate that the PB2 subunits of these two H5N1 strains
differ in their properties when reconstituted into hybrid RNP with
other influenza strains, and HK PB2 has a strong inhibitory effect
on RNP activity.
Rescue of the hybrid RNP activity by mutations in HK PB2
Despite originating from the same H5N1 subtype, the amino
acid sequence of PB2 between HK and VN differs at 26 positions
out of 759 amino acids (Figure 2A). Since HK PB2 showed a
severe reduction in RNP activity when introduced into other
polymerases as compared to VN PB2, we speculated that a
substitution of these 26 amino acids of HK PB2 for the VN PB2
sequence might rescue the impaired RNP activity. To test this,
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positions, except for 4 residues at positions 190, 299, 340 and 355
because they were similar basic (R and K) amino acids. Firstly, we
focused on residues 189 to 199 because amino acids differences
between HK PB2 and VN PB2 were clustered in this region.
However, all mutant polymerases K189E, K194Q, N195D,
N197K and S199A showed still inactive levels of the RNP activity
comparable to WT HK PB2 (Figure 2B, lanes 2 to 7). Next, we
focused on residue 627 because PB2 K627 is known to be an
important determinant for the virulence and host adaptation of
influenza virus. A mutant polymerase E627K of HK PB2 rescued
significant activity and the levels of all 3 RNA species (mRNA,
cRNA and vRNA) reached about 50% of the VN PB2 activity
(Figure 2B, compare lanes 17 with lane 10). In order to attempt to
rescue RNP activity further, we then introduced additional
mutations into the E627K mutant one by one. Mutations at C-
Figure 1. Comparison of RNP activities containing hybrid polymerases between H5N1 strains and human strains in vivo. Polymerase
subunits of human strains of A/WSN/1933 (H1N1) (W), A/Kurume/K0910/2009 (H1N1) (S) and A/NT/60/1968 (H3N2) (N) were replaced with the
corresponding subunits of A/HongKong/156/1997 (H5N1) (H) (left 3 panels) or A/Vietnam/1194/2004 (H5N1) (V) (right 3 panels). The RNP was
reconstituted in 293T cells by transfection of plasmids expressing various combinations of polymerase subunits, and WSN derived NP and vNA. Total
RNA was extracted 30 h posttransfection. Transcript products of viral mRNA, cRNA and vRNA were measured by primer extension and its positions
are indicated on the right. The expected size of mRNA, cRNA, vRNA and 5S rRNA as an internal control are 169–177 nt, 160 nt, 129 nt and 100 nt,
respectively.
doi:10.1371/journal.pone.0032634.g001
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(Figure 2B, lanes 11–16). However, the additional mutation at
M524T significantly increased activity, specifically of cRNA and
vRNA, reaching the equivalent level to VN PB2 (Figure 2B,
compare lanes 19 with 21). Subsequent mutation at Q508R
further slightly increased vRNA to higher levels than VN PB2
(Figure 2B, lane 20), although the mRNA level was still lower than
VN PB2. These results suggest a specific role of the positions 508
and 524 on the RNA replication (cRNA and vRNA synthesis), not
on transcription (mRNA synthesis). The level of mRNA was fully
rescued and the level of all three RNA species nearly reached the
VN PB2 level when a mutation was subsequently introduced at
T108A (Figure 2B, lane 24). Additional mutations did not increase
the RNP activity further (Figure 2B, lanes 25–31). Overall, we
conclude that at least 4 positions of 108, 508, 524 and 627 in HK
PB2 are responsible for the impaired RNP activity reconstituted
from hybrid polymerase.
Mutations at position 108, 508, 524 and 627 in VN PB2
impair the RNP activity
Since four amino acids in HK PB2 were found to be critical for
rescuing activity of the hybrid RNP, it is conceivable that
substitution of amino acids at the same position in VN PB2 by
the HK PB2 sequence might decrease the RNP activity. Single
Figure 2. Effects of mutations in the HK PB2 subunit on the impaired RNP activity reconstituted from hybrid polymerase. (A)
Alignment of amino acid residues of PB2 subunit differing between HK and VN of H5N1 strains. All positions of HK PB2, except for 4 residues (asterisk)
that were similar basic amino acids, were sequentially substituted for VN PB2 sequences. (B) Steady state level of NA vRNA, mRNA, and cRNA in WSN
(W) RNP reconstituted from hybrid polymerase by replacing only PB2 subunit with the HK PB2 wild type (H) (lanes 2 and 9), HK PB2 mutants (lanes 3–
7, 10–16, 18–20, 22–26 and 28–30) and VN PB2 (V) (lanes 17, 21, 27 and 31). The numbers in HK PB2 mutants indicate mutated positions in HK PB2.
Arrows indicate HK PB2 mutants which showed significant increase of RNP activity. The positions found to be important for the rescue of the RNP
activity are highlighted.
doi:10.1371/journal.pone.0032634.g002
PB2 Restricts Genetic Reassortment
PLoS ONE | www.plosone.org 4 February 2012 | Volume 7 | Issue 2 | e32634mutant R508Q or double mutant R508Q/T524M showed a slight
decrease in activity compared with VN PB2 (Figure 3, lanes 3 and
4), while single mutant K627E showed a significant decrease in
activity to less than 30% of mRNA, and ,10% of cRNA and
vRNA (Figure 3, lane 5). The synthesis of all three RNA species
was further decreased in a double mutant R508Q/K627 (Figure 3,
lane 7), and markedly reduced to undetectable levels in a fourfold
mutant A108T/R508Q/T524M/K627E (Figure 3, lane 9). Taken
together, these results support our conclusion that 4 positions at
108, 508, 524 and 627 in HK PB2 are responsible for the optimal
activity of RNP reconstituted from hybrid polymerase. We cannot
exclude the possibility that residues other than 108, 508, 524 and
627 may also be important for RNP activity, because we have not
tested HK PB2 carrying mutations at only these 4 positions.
HK PB2 impairs neither the assembly of trimeric complex
nor the in vitro polymerase activity
To address the question why HK PB2 severely inhibited the
activity of RNP reconstituted from hybrid polymerase, we initially
examined whether HK PB2 affects the correct assembly of the
trimeric complex of PB1, PB2, and PA. To allow the purification
of trimeric complex, a C-terminally TAP-tagged PA was co-
expressed with PB1 and PB2 in 293T cells, and the trimeric
complex was affinity purified by a TAP method and quantitatively
adjusted (see materials and methods). In the case of HK PB2, the
expression level of three subunits was comparable to WSN
polymerase or VN PB2 hybrid polymerase (Figure 4A, lane 2),
although its RNP activity was impaired. A similar expression level
of three subunits was observed in all four HK PB2 mutants having
significant RNP activity (Figure 4A, lanes 3–6). Thus, HK PB2
does not appear to affect the correct assembly of the trimeric
complex.
An alternative explanation for the defect of RNP activity is a
loss of the polymerase activity. The binding of RNA polymerase to
the promoter is an essential step to initiate RNA synthesis.
Therefore, the promoter binding activity of the polymerase in vitro
was assayed by UV cross-linking, then subsequent initiation of
RNA synthesis was analyzed by dinucleotide replication assay (see
materials and methods). Surprisingly, HK PB2 WT showed a
strong activity to bind both vRNA and cRNA promoters (.200%
of VN PB2 [Figure 4B and 4D, lane 2]), in spite of the loss of the
RNP activity. However, the K627E mutation significantly reduced
vRNA and cRNA promoter binding activities to the level of VN
PB2 (100–150% of VN PB2 [Figure 4B and 4D, lane 3]). This
suggests that position 627 might be involved in promoter binding.
Additional mutations did not further affect promoter binding
(Figure 4B and 4D, lanes 4–6). The promoter binding activity of
the polymerase correlated well with the replication initiation
activity and essentially similar results were observed. HK PB2 WT
synthesized significant yields of ApG in both vRNA and cRNA
templates (.200% of VN PB2 [Figure 4C and 4E, lane 2]).
However, K627E mutation remarkably reduced the replication
initiation activity (approximately 150% of VN PB2 [Figure 4C and
4E, lane 3]). Additional mutations had little effect on the activity
(Figure 4C and 4E, lanes 4–6). Overall these results suggest that
the impaired RNP activity by HK PB2 was not due to the defect in
the assembly of the polymerase and the loss of the in vitro
polymerase activity.
HK PB2 impairs the accumulation of ribonucleoprotein
complex
Another possible explanation for the loss of RNP activity is a
defect in the assembly of RNP. To test this possibility, we purified
and evaluated the amount of RNP accumulated in vivo. To allow
RNP purification, a C-terminally TAP-tagged PA was coexpressed
and the reconstituted RNP was affinity purified by a TAP method
(see materials and methods). The amount of TAP-purified RNP
was measured by Western blotting with specific antibodies for NP
(Figure 5B and 5D). Addition of a C-terminal TAP tag at PA did
not interfere with the RNP activity (data not shown). In the case of
hybrid RNP containing VN PB2, NP was clearly detected, with an
essentially similar level to that of WSN PB2 (Figure 5B and 5D,
lanes 1 and 5). This indicates that the VN PB2 does not affect in
vivo accumulation of RNP. By contrast, in the hybrid containing
the HK PB2 (Figure 5A, lane 2) insignificant levels of RNP were
detected (Figure 5B and 5D, lane 2), indicating the defect in the
replication of RNP. Nevertheless the trimeric complex was
correctly formed (Figure 5A, lane 2) and overall NP was expressed
at equivalent levels to those seen in the wild-type WSN or VN
(Figure 5C, lane 2 compared with lanes 1 and 5). These results
clearly showed that HK PB2 had a major inhibitory effect on the
accumulation of hybrid RNP. Importantly, the single mutation at
627 rescued significant accumulation of RNP, with an essentially
similar level to that of VN PB2 (Figure 5B and 5D, lanes 3 and 5),
suggesting that position 627 is obviously involved in the
accumulation of RNP. However, the single mutation at 627 did
not fully rescue the RNP activity and additional mutation at 108,
508 and 524 were required for the full activity (Figure 2). A
significant level of RNP accumulation comparable to that of WSN
PB2 or VN PB2 was also observed in the HK PB2 mutant with full
RNP activity (Figure 5B and 5D, lane 4). Overall, these results
suggested that HK PB2 significantly impairs the accumulation of
RNP, explaining the loss of the RNP activity.
Discussion
The genetic reassortment between two different influenza A
viruses can generate 256 (2
8) genotypes theoretically. However,
systematic studies by using reverse genetics have shown that the
number of replicative reassortant viruses is apparently limited
Figure 3. Effects of mutations in the VN PB2 subunit on the
RNP activity reconstituted from hybrid polymerase. RNP of WSN
(W) was reconstituted from hybrid polymerase by replacing only PB2
subunit with the VN PB2 wild type (V) (lane 2) or VN PB2 mutants (lanes
3–9). The steady state level of vRNA, mRNA, and cRNA was measured by
primer extension. The numbers indicate mutated positions in VN PB2.
doi:10.1371/journal.pone.0032634.g003
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and A/Wyoming/3/03 (H3N2), or A/equine/Prague/1/56
(H7N7) and A/Yokohama/2017/03 (H3N2), could yield only 63
(254 parent virus) or 29 (256 parent virus) hybrid genotypes,
respectively [23,25]. In this study, we focused on the role of the
RNA polymerase on the restriction of genetic reassortment of
influenza virus. We constructed artificial hybrid RNPs by
replacing the polymerase subunits of H1N1 or H3N2 with the
corresponding subunits from two strains of H5N1, HK and VN,
and evaluated the RNP activity by measuring steady state levels of
mRNA, vRNA and cRNA. We found that the PB2 subunit of HK
had a strong inhibitory effect on the activity both in transcription
(mRNA synthesis) and replication (cRNA and vRNA synthesis),
because it alone could inhibit the activity of all other strains
(Figure 1). HK PB1 and HK PA did not appear to have this effect.
These results are consistent with the observation that the PB2
subunit of avian or pandemic H1N1 has often lead to a reduction
of activity in hybrid polymerase with human strains [23,24,31].
Interestingly, the pandemic human H2N2 and H3N2 does not
carry avian PB2. Thus, we suggest that an introduction of the PB2
from certain avian H5N1 strains into human strains might be a
disadvantage for successful genetic reassortment. Our results
cannot exclude the possibility that NP may be involved, because
other reassortment studies suggested the importance of NP in host
adaptation [30,32,33,34].
Although few studies have described the mechanism of
restriction of genetic reassortment, the loss of RNP activity in a
hybrid experiment between equine H7N7 and human H3N2
strains was linked to the inability of assembly of the polymerase
trimeric complex [25]. On the contrary, the polymerase trimeric
complex was properly formed and no significant reduction of the
in vitro polymerase activity was seen, even though the RNP
activity was impaired when HK PB2 was introduced into the
polymerase of other influenza strains (Figure 5). Our results clearly
showed that the defect of RNP activity is related to poor
accumulation of RNP. The RNP is formed by the association of
vRNA to NP and polymerase trimeric complex. We can only
speculate that HKPB2 may affect the efficiency of interactions of
the polymerase with NP [35,36], vRNA and cellular factors
[37,38] which are involved in the RNP assembly, thereby affecting
RNP accumulation.
The correlation between the presence of lysine at position 627
of PB2 and the efficiency of RNP accumulation has recently been
reported for H1N1 strains. The KRE mutation at PB2 627 of
human strain A/WSN/1933 (H1N1) significantly decreased the
accumulation of RNP reconstituted in human 293T cells and
resulted in the concomitant decrease in the RNP activity [39]. In
addition, the ERK mutation at PB2 627 of avian strain A/
Mallard/Marquenterre/MZ237/1983 (H1N1) in 293T cells
increased the accumulation of RNP [19]. These observations are
in agreement with our data in H5N1 strains, indicating that the
accumulation of RNP was almost fully rescued by the ERK
mutation at 627. However, the single mutation at 627 could only
partially rescue the RNP activity, and an additional mutation at
108, 508 and 524 was required for full recovery of the RNP
activity (Figure 2). Thus, it is possible that amino acid at PB2 627 is
mainly involved in the structural assembly of RNP, but other
positions 108, 508 and 524 also play an important role in
Figure 4. Promoter binding activity and replication initiation activity of HK PB2 mutants. (A) Partially purified polymerases analyzed by
silver-stained 7.5% SDS-PAGE. Hybrid WSN (W) polymerase replaced only PB2 subunit with HK PB2 wild type (H) (lanes 2), HK PB2 mutants (lanes 3–6)
and VN PB2 (V) (lane 7) was transiently expressed in 293T cells and partially purified by using TAP-tagged PA (see materials and methods). The
numbers in HK PB2 mutants indicate mutated positions in HK PB2. The highlighted numbers are important for the rescue of the RNP activity. (B)U V
cross-linking of model vRNA and cRNA promoters to hybrid polymerases. Purified and quantified polymerases were incubated with
32P-labelled 39
strand of the vRNA promoter in the presence of the unlabelled 59 strand of the vRNA promoter (upper panel), or
32P -labelled 39 strand of the cRNA
promoter in the presence of the unlabelled 59 strand of the cRNA promoter (lower panel). Lane numbers correspond to the numbers in (A). The
positions of the cross-linked products are indicated on the right. (C) ApG synthesis with a model vRNA promoter (upper panel) or cRNA promoter
(lower panel). Lane numbers correspond to the numbers in (A). The position of the specific ApG product is indicated on the right. (D and E)
Quantification of results obtained in panels B and C, respectively, by phosphorimaging. Data are expressed as percentages relative to VN PB2 (lane 7)
(mean 6 standard deviation; n=3). Black bars, model vRNA promoter; white bars, model cRNA promoter. * shows statistical significance at P,0.01 in
a Student’s t-test.
doi:10.1371/journal.pone.0032634.g004
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modulate the interaction with PB1 and preferentially affect
transcriptional activity (Figure 2, lane 24), since it is close to the
PB1 binding site (Figure 6A) [29,40]. Positions 508 and 524 are
close to cap-binding sites [10,41] and the 627 domain (538–693)
[42]. These positions, we speculate, may affect RNA binding, the
function of 627 residue, or may modulate the interaction with host
chaperone proteins, such as Hsp90, Hsp70 and CCT [43,44,45].
Importantly, an alignment of the PB2 sequences from typical
human influenza viruses and avian influenza viruses currently
circulating in poultry in some countries, with differing HA and NA
subtypes, demonstrated that three positions 108, 508 and 524 were
highly conserved among influenza A viruses (Figure 6B). This
suggests that these residues are important for the function of RNP
in influenza A viruses. In addition, an alignment of HK PB2
sequence with 60 human isolates of H5N1 demonstrated that
Q508 and M524 were conserved only less than 2%. Perhaps, these
residues might define specific features of HK PB2.
The ERK mutation at HK PB2 627 showed a significant
reduction in vRNA promoter and cRNA promoter bindings in
cross-linking experiments (Figure 4B). PB2 has been shown to bind
both vRNA and cRNA promoters [16,40], but the precise binding
site in PB2 has not yet been identified. Our findings suggest that
the PB2 627 is involved in vRNA and cRNA promoter binding. A
reduction of the promoter binding is clearly consistent with the
reduction of replication initiation activity in vitro (Figure 4C).
Structural studies of the C-terminal region of PB2 have shown that
the KRE mutation at PB2 627 disrupts the positively charged
surface of the protein without altering structure [42]. We propose
that the mutation at HK PB2 627 alter the charge of the protein,
thereby affecting the promoter binding and subsequent RNA
synthesis.
A purified H5N1polymerase shows significantly higher poly-
merase activity in vitro when compared to human strain A/WSN/
33 (H1N1) [14,46,47]. The polymerase activity of WSN was
increased by the introduction of the PB2 or PA subunit of H5N1.
These findings are consistent with our observations that the HK
PB2 remarkably enhanced the promoter binding activity and
replication initiation activity of WSN polymerase (Figure 4).
However, the HK PB2 significantly reduced the polymerase
activity in vivo in the RNP reconstitution assay. This different
result between in vitro and in vivo is also in agreement with the
previous reports [14,47]. We speculate that a significant reduction
of the polymerase activity in vivo, in spite of its strong activity in
vitro, could be explained by the poor accumulation of RNP.
Introduction of HK PA into SW and NT polymerases increased
the synthesis of mRNA, cRNA and vRNA (Figure 1, lanes 20 and
36). It is also worth noting that HK PA obviously relieved the
inhibitory effect of HK PB2 (Figure 1, lanes 22 and 38). This
suggests a functional cooperation between PB2 and PA [48].
Figure 5. Accumulation of RNP reconstituted from hybrid polymerase. Hybrid RNP was reconstituted in a background of WSN (W) by
replacing only PB2 subunit with the HK PB2 wild type (H) (lanes 2), HK PB2 mutants (lanes 3–4) and VN PB2 (V) (lanes 5). Reconstituted RNP in 293T
cells was partially purified by using TAP-tagged PA (see materials and methods). The numbers in HK PB2 mutants indicate mutated positions in HK
PB2. (A and B) Partially purified RNP analyzed by silver-stained 7.5% SDS-PAGE, and by western blotting using specific antibodies for NP, respectively.
(C) Expression of NP in total cell lysate, analyzed by western blotting using specific antibodies for NP by 7.5% SDS-PAGE. The positions of PB1, PB2,
PA-TAP and NP are shown on the right. (D) Quantification of results obtained in panel B by phosphorimaging. Data are expressed as percentages
relative to VN PB2 (lane 5) (mean 6 standard deviation; n=3). * shows statistical significance at P,0.01 in a Student’s t-test.
doi:10.1371/journal.pone.0032634.g005
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PLoS ONE | www.plosone.org 7 February 2012 | Volume 7 | Issue 2 | e32634These results are consistent with recent RNP reconstitution studies
suggesting that PA plays a major role in increasing activities of
hybrid polymerase [14,47,49]. However, such a tendency could
not be observed in hybrid WSN polymerase, suggesting that the
PA subunit cannot always overcome the restriction of genetic
reassortment.
In summary, we have found that the PB2 subunit of influenza
A/HongKong/156/1997 (H5N1) has a strong inhibitory effect on
the RNP activity when introduced into the polymerase of other
influenza strains. In addition, four residues at positions 108, 508,
524 and 627 of the PB2 subunit appear to be important
determinants that are involved in the accumulation of functional
RNP and in modulating the polymerase activity. These results
may suggest a possible mechanism by which the generation of
replicative reassortant virus of influenza is highly restricted.
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